Can ThyroCare Outdo Dr. LalPath Labs’ IPO?
“Dr. Lal PathLabs IPO subscribed 33.41 times”
“Dr Lal PathLabs zooms 50% on debut”
Will the latest Private Equity-backed diagnostic chain to go public — Thyrocare Technologies — also enjoy similar headlines to Dr. LalPath when it completes it IPO — opening this week — and subsequently lists? Venture Intelligence maps the financial performance, investor returns and the valuation growth of Thyrocare (and benchmarks it to its peer that went public in Dec-15).
Interested in seeing transaction level data for PE/VC Investors in Thyrocare? Take a trial to Venture Intelligence Deal Databases with tons of information on transactions, valuations and financials on private companies.
Like this infographic? Sign up for more via our FREE newsletter.
Venture Intelligence is India’s longest serving provider of data and analysis on Private Company Financials, Transactions (private equity, venture capital and M&A) & their Valuations in India.